D. Vanjak
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Clostridium difficile and Clostridium perfringens research 2
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- Dominique Decré (1 shared paper)M Wolff (1 shared paper)Jean Christophe Lucet (1 shared paper)Sylvie Chevret (1 shared paper)Jean Pierre Bedos (1 shared paper)B. Régnier (1 shared paper)Jean‐Christophe Lucet (2 shared papers)Antoine Andremont (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)Eurosurveillance (1 paper)Infection Control and Hospital Epidemiology (1 paper)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)Vaccine (1 paper)
- Partner nations
- FranceSwitzerlandGreece
In The Last Decade
D. Vanjak
14 papers receiving 487 citations
Peers
Comparison fields: 5 of 57
- Applied Microbiology and Biotechnology 116
- Molecular Medicine 249
- Critical Care and Intensive Care Medicine 72
- Endocrinology 53
- Pharmacology 97
Countries citing papers authored by D. Vanjak
This map shows the geographic impact of D. Vanjak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vanjak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vanjak more than expected).
Fields of papers citing papers by D. Vanjak
This network shows the impact of papers produced by D. Vanjak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vanjak. The network helps show where D. Vanjak may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Vanjak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 173 | |
| 2 | 2004 | 154 | |
| 3 | 2010 | 52 | |
| 4 | 2016 | 32 | |
| 5 | 2012 | 30 | |
| 6 | 2007 | 17 | |
| 7 | 1995 | 16 | |
| 8 | 2014 | 12 | |
| 9 | 2006 | 9 | |
| 10 | [Infectious endocarditis of the tricuspid valve in patients with endocardial pacemakers]. | 1990 | 9 |
| 11 | 2017 | 3 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 1 | |
| 14 | [Influenza and other viral diseases, historical reminders of large pandemics]. | 2009 | 1 |
About D. Vanjak
D. Vanjak is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology and Pharmacology, having authored 14 papers that have together received 510 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Clostridium difficile and Clostridium perfringens research (2 papers), COVID-19 and healthcare impacts (1 paper), Bacterial Infections and Vaccines (1 paper), Infective Endocarditis Diagnosis and Management (1 paper) and Pericarditis and Cardiac Tamponade (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (116 citations), Molecular Medicine (249 citations), Critical Care and Intensive Care Medicine (72 citations), Endocrinology (53 citations) and Pharmacology (97 citations). D. Vanjak has collaborated with scholars based in France, Switzerland and Greece. Frequent co-authors include Dominique Decré, M Wolff, Jean Christophe Lucet, Sylvie Chevret, Jean Pierre Bedos, B. Régnier, Jean‐Christophe Lucet, Antoine Andremont, Andreas Karabinis and Stéphanie Belloc. Their work appears in journals such as Clinical Infectious Diseases, Eurosurveillance, Infection Control and Hospital Epidemiology, European Journal of Clinical Microbiology & Infectious Diseases and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.